{
    "root": "363540ff-7b66-daa5-e063-6394a90a3396",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DOXYCYCLINE",
    "value": "20250528",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A CORN",
            "code": "AG9B65PV6B"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "DOXYCYCLINE",
            "code": "N12000U13O"
        }
    ],
    "indications": "To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n                  Doxycycline is indicated for the treatment of the following infections:\n                  Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by\n \n  Rickettsiae.\n                  \n                  Respiratory tract infections caused by\n \n  Mycoplasma pneumoniae.\n                  \n                  Lymphogranuloma venereum caused by\n \n  Chlamydia trachomatis.\n                  \n                  Psittacosis (ornithosis) caused by\n \n  Chlamydophila psittaci.\n                  \n                  Trachoma caused by\n \n  Chlamydia trachomatis,although the infectious agent is not always eliminated as judged by immunofluorescence.\n\n \n                  Inclusion conjunctivitis caused by\n \n  Chlamydia trachomatis.\n                  \n                  Uncomplicated urethral, endocervical or rectal infections in adults caused by\n \n  Chlamydia trachomatis.\n                  \n                  Nongonococcal urethritis caused by\n \n  Ureaplasma urealyticum.\n                  \n                  Relapsing fever due to\n \n  Borrelia recurrentis.\n                  \n                  Doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms:\n                  Chancroid caused by\n \n  Haemophilus ducreyi.\n                  \n                  Plague due to\n \n  Yersinia pestis.\n\n \n                  Tularemia due to\n \n  Francisella tularensis.\n\n \n                  Cholera caused by\n \n  Vibrio cholerae.\n\n \n                  Campylobacter fetus infections caused by\n \n  Campylobacter fetus.\n\n \n                  Brucellosis due to\n \n  Brucella species(in conjunction with streptomycin).\n\n \n                  Bartonellosis due to\n \n  Bartonella bacilliformis.\n                  \n                  Granuloma inguinale caused by\n \n  Klebsiella granulomatis.\n                  \n                  Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.\n                  Doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  \n                     Escherichia coli\n                  \n                  \n                     Enterobacter aerogenes\n                  \n                  \n                     Shigella species\n                  \n                  \n                     Acinetobacter species\n                  \n                  Respiratory tract infections caused by\n \n  Haemophilus influenzae.\n                  \n                  Respiratory tract and urinary tract infections caused by\n \n  Klebsiella species.\n                  \n                  Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  Upper respiratory infections caused by\n \n  Streptococcus pneumoniae.\n\n \n                  Anthrax due to\n \n  Bacillus anthracis,including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized\n \n  Bacillus anthracis.\n                  \n                  When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections:\n                  Uncomplicated gonorrhea caused by\n \n  Neisseria gonorrhoeae.\n                  \n                  Syphilis caused by\n \n  Treponema pallidum.\n                  \n                  Yaws caused by\n \n  Treponema pallidumsubspecies\n \n  pertenue.\n                  \n                  Listeriosis due to\n \n  Listeria monocytogenes.\n                  \n                  Vincent's infection caused by\n \n  Fusobacterium fusiforme.\n                  \n                  Actinomycosis caused by\n \n  Actinomyces israelii.\n                  \n                  Infections caused by\n \n  Clostridium species.\n                  \n                  In acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides.\n                  In severe acne, doxycycline may be useful adjunctive therapy.",
    "contraindications": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.",
    "warningsAndPrecautions": "Doxycycline capsules USP, 100 mg are brown opaque cap and yellow opaque body imprinted with \"LU\" on cap in white ink and \"M73\" on the body in black ink filled with light yellow to grey colored blend.\n                  Each capsule contains doxycycline monohydrate USP equivalent to 100 mg doxycycline.\n                  Doxycycline capsules USP, 100 mg is available in:\n                  \n                  NDC: 70518-0213-00\n                  NDC: 70518-0213-01\n                  NDC: 70518-0213-02\n                  NDC: 70518-0213-03\n                  NDC: 70518-0213-04\n                  NDC: 70518-0213-05\n                  NDC: 70518-0213-06\n                  NDC: 70518-0213-07\n                  NDC: 70518-0213-08\n                  NDC: 70518-0213-09\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 20 in 1 BLISTER PACK\n                  PACKAGING: 14 in 1 BOTTLE PLASTIC\n                  PACKAGING: 20 in 1 BOTTLE PLASTIC\n                  PACKAGING: 42 in 1 BOTTLE PLASTIC\n                  PACKAGING: 2 in 1 BOTTLE PLASTIC\n                  PACKAGING: 100 in 1 BOTTLE PLASTIC\n                  PACKAGING: 14 in 1 BLISTER PACK\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  \n                  Store at 25째C (77째F); excursions permitted to 15 to 30째C (59 to 86째F) [see USP controlled room temperature]. Protect from light.\n                  Dispense in a tight, light-resistant container as defined in the USP/NF.\n                  Dispense in a tight container [see USP].\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines."
}